| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |